SCHEMBL6826344

SCHEMBL6826344

C/C(=N\O)c1ccc(Nc2ncc(Br)c(Nc3ccc(F)cc3)n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.55
CDK1 P06493 3/20 0.54
CHEK1 O14757 1/20 0.53
NTRK2 Q16620 1/20 0.53
AURKA O14965 5/20 0.52
IGF1R P08069 3/20 0.52
PTK2 Q05397 1/20 0.48
CDK2 P24941 1/20 0.46
KDR P35968 1/20 0.46
SYK P43405 2/20 0.46
EGFR P00533 2/20 0.45
CDK19 Q9BWU1 1/20 0.45
ALK Q9UM73 1/20 0.45
GSK3A P49840 1/20 0.44
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6826345 1.00 GSK3B (0.55) GSK3BCDK1CHEK1NTRK2AURKA
SCHEMBL6829248 0.85 GSK3B (0.64) GSK3BCDK1CHEK1NTRK2AURKA
SCHEMBL5262926 0.81 GSK3B (0.81) GSK3BCDK1CHEK1NTRK2AURKA
SCHEMBL6826392 0.81 AURKA (0.67) GSK3BCDK1AURKAIGF1RCDK2
SCHEMBL6829175 0.75 SYK (0.83) GSK3BCDK1AURKAIGF1RSYK
SCHEMBL5262378 0.71 GSK3B (1.00) GSK3BCDK1CHEK1NTRK2AURKA
SCHEMBL6829108 0.70 CDK2 (0.64) GSK3BCDK1CHEK1NTRK2AURKA
SCHEMBL6829794 0.70 CDK2 (0.64) GSK3BCDK1CHEK1NTRK2AURKA
SCHEMBL6826387 0.70 CDK2 (0.64) GSK3BCDK1CHEK1NTRK2AURKA
SCHEMBL656765 0.70 AURKA (1.00) GSK3BCDK1NTRK2AURKAIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004046118-A2 2-4-(DI-PHENYL-AMINO)-PYRIMIDINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2004-06-03 WO disclosed